Revenue
2019
2020
2021
2022
2023
NP Life Sciences Health Industry Group Inc. (ACAT)
Price$0.1300Cached quote
Financial statements
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue | $164,621 | $102,002 | $34,992 | $15,000 | $43,000 |
| Operating expenses | $165,311 | $120,857 | $100,673 | — | — |
| Operating income | −$690 | −$18,855 | −$65,681 | −$131,091 | −$108,859 |
| Operating margin | −0.42% | −18.48% | −187.70% | −873.94% | −253.16% |
| EBITDA | −$690 | −$18,855 | −$65,681 | — | — |
| EBITDA margin | −0.42% | −18.48% | −187.70% | — | — |
| Net income | −$2,935 | −$18,856 | −$65,677 | −$131,065 | −$108,827 |
| Net profit margin | −1.78% | −18.49% | −187.69% | −873.77% | −253.09% |
| Basic EPSper basic share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted EPSper diluted share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Owners
Reported shareholders